Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. (AXDX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
axdx · stock forecast · 4 analysts (3M) · FMP · updated Feb 3, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Hold
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.01
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↑ 0.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AXDX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-04-01 | Craig-Hallum | Maintains | Hold→Hold |
| 2022-03-09 | Craig-Hallum | Downgrade ↓ | Buy→Hold |
| 2020-08-10 | Piper Sandler | Maintains | Overweight→Overweight |
| 2019-09-27 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2018-11-07 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2017-12-19 | BTIG Research | Downgrade ↓ | Buy→Neutral |
| 2017-12-13 | BTIG Research | Downgrade ↓ | Buy→Neutral |
| 2016-08-09 | JP Morgan | Maintains | Overweight→Overweight |
| 2015-08-25 | BTIG Research | Upgrade ↑ | Neutral→Buy |
Wall Street analysts have recently issued updated ratings on Accelerate Diagnostics, Inc. (AXDX) stock. Of the recent 9 rating actions, 1 were upgrades and 5 were downgrades. 4 analysts currently cover AXDX.
Analyst Recommendation Trends
AXDX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$13M
↑ 6.4% YoY
Revenue Next Year
$12M
↓ 1.6% YoY
EPS This Year
$-7.78
EPS Next Year
$-4.83
↓ 38.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast AXDX EPS of $-7.78 for the current fiscal year, based on estimates from 1 analysts. The AXDX revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AXDX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AXDX price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The AXDX short-term stock prediction for tomorrow is $0.01 (+0.00%).
Accelerate Diagnostics, Inc. trades on NASDAQ under the ticker AXDX. The AXDX stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 25% of covering analysts.
Frequently asked questions
AXDX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month AXDX price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.